tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Amsellem, 370 are a BUY (75.05%), 113 are a HOLD (22.92%), 10 are a SELL (2.03%).
Analyst David Amsellem, currently employed at PIPER SANDLER, carries an average stock price target met ratio of 59.2% that have a potential upside of 29.97% achieved within 240 days.
David Amsellem’s has documented 964 price targets and ratings displayed on 53 stocks. The coverage is on Healthcare, Consumer Defensive, Financial Services sectors.
Most recent stock forecast was given on ABBV, AbbVie at 23-Jun-2026.
Analyst best performing recommendations are on RVNC (REVANCE THE).
The best stock recommendation documented was for RVNC (REVANCE THE) at 8/9/2024. The price target of $6 was fulfilled within 3 days with a profit of $2.47 (69.97%) receiving and performance score of 233.24.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 29-Nov-2017
$8.5
$0.28 (3.41%)
4 years 8 months 12 days ago
(18-Nov-2021)
0/3 (0%)
$0.33 (4.04%)
Hold Since 13-Oct-2021
$8
$-0.22 (-2.68%)
$10
4 years 9 months 17 days ago
(13-Oct-2021)
1/7 (14.29%)
$-0.07 (-0.87%)
6
Buy Since 12-Jan-2016
$8
$-0.22 (-2.68%)
$7
4 years 9 months 17 days ago
(13-Oct-2021)
4/5 (80%)
$-0.07 (-0.87%)
95
Buy Since 17-Aug-2017
$14
4 years 9 months 17 days ago
(13-Oct-2021)
3/7 (42.86%)
$9.25 (194.74%)
87
Buy
$6
$-2.22 (-27.01%)
$20
4 years 9 months 18 days ago
(12-Oct-2021)
0/2 (0%)
$3.2 (23.94%)
Which stock is David Amsellem is most bullish on?
Which stock is David Amsellem is most reserved on?
What Year was the first public recommendation made by David Amsellem?
